Amicus Therapeutics Inc
NASDAQ:FOLD

Watchlist Manager
Amicus Therapeutics Inc Logo
Amicus Therapeutics Inc
NASDAQ:FOLD
Watchlist
Price: 9.57 USD 0.74% Market Closed
Updated: May 18, 2024

Amicus Therapeutics Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amicus Therapeutics Inc
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Amicus Therapeutics Inc
NASDAQ:FOLD
Depreciation & Amortization
-$8.7m
CAGR 3-Years
-1%
CAGR 5-Years
-15%
CAGR 10-Years
-18%
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Amicus Therapeutics Inc's Depreciation & Amortization?
Depreciation & Amortization
-8.7m USD

Based on the financial report for Mar 31, 2024, Amicus Therapeutics Inc's Depreciation & Amortization amounts to -8.7m USD.

What is Amicus Therapeutics Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-18%

Over the last year, the Depreciation & Amortization growth was -68%. The average annual Depreciation & Amortization growth rates for Amicus Therapeutics Inc have been -1% over the past three years , -15% over the past five years , and -18% over the past ten years .